Distinguished speakers include:
- Ralf Huss, VP & Head Therapeutic Cell Initiative, Research Therapeutic Modalities, Pharma Research and Early Development (pRED), F. Hoffman-La Roche, Germany
- Sean Hu, Chairman & CEO, Shenzhen Beike Biotechnology, China
- Robert Wild, Chief Scientific Officer, Oncology Research, Eli Lilly and Company, USA
- Boenjamin Setiawan, Founder and Senior Advisor, PT. Kalbe Farma Tbk, Indonesia
- Masanori Fukushima, Chairman & Director, Foundation of Biomedical Research and Innovation (FBRI) & Translational Research Informatics Center (TRI), Japan
- Chandra Viswanathan, SVP Regenerative Medicine, Reliance Life Sciences, India
- Wilai Bundittanugula, Director, Drug Control Division, Thai FDA, Thailand
- Koji Nakamura, President & CEO, LivTech, Inc., Japan
- D. Balasubramanian, Director of Research, L.V. Prasad Eye Institute, India
- Kim Jeom Beong, Director, Hans Schoeler Stem Cell Research Center (HSSCRC), Ulsan National Institute of Science & Technology (UNIST), Korea
For more information, visit www.terrapinn.com/stemcellasia.
Special promotion for subscribers!
Register before 31 July 2011 and quote ‘SCA20’ to get 20% off prevailing early bird prices! Contact Debby Lim at +65 6322 2710 or email email@example.com to register today!